The underlying mechanism by which Ezetimibe triggers ER stress and vacuolation was further elucidated by evaluating the PI3K/AKT/mTOR signaling pathway in HCC cells overexpressing NPC1L1 and treated with or without Ezetimibe. Here, AKT1 is linked to hepatocellular carcinoma.